Ryan McDonald, Associate Editorial Director for CURE®, has been with the team since February 2020 and has previously covered medical news across several specialties prior to joining MJH Life Sciences. He is a graduate of Temple University, where he studied journalism and minored in political science and history. He considers himself a craft beer snob and would like to open a brewery in the future. During his spare time, he can be found rooting for all major Philadelphia sports teams. Follow Ryan on Twitter @RMcDonald11 or email him at email@example.com.
CURE® compiled a roundup of five recent reports patients with lymphoma may have missed.
CURE® presents the following reports on the most recent updates and developments in lymphoma that patients may have missed.
These reports include research of a novel CAR-T cell therapy in advanced Hodgkin lymphoma, as well an updated analysis of breast-implant associated lymphoma.